Chelating agents for human diseases related to aluminium overload

被引：89
作者：
Crisponi, G. [1 ]
Nurchi, V. M. [1 ]
Bertolasi, V. [2 ,3 ]
Remelli, M. [2 ]
Faa, G. [4 ]
机构：
[1] Univ Cagliari, Dipartimento Sci Chim, I-09042 Cagliari, Italy
[2] Univ Ferrara, Dipartmento Chim, I-44121 Ferrara, Italy
[3] Univ Ferrara, Ctr Strutturist Diffrattometr, I-44121 Ferrara, Italy
[4] Univ Cagliari, Dipartimento Citomorfol, Div Anat Patolog, I-09042 Cagliari, Italy
来源：
COORDINATION CHEMISTRY REVIEWS | 2012年 / 256卷 / 1-2期
关键词：
Aluminium; Aluminium overload; Chelating agent; Complex formation constant; Aluminium related diseases; INTESTINAL-ABSORPTION; GASTROINTESTINAL ABSORPTION; DRINKING-WATER; BLADDER-CANCER; HUMAN-SERUM; METAL-IONS; AL-III; MACROPHAGIC MYOFASCIITIS; DIALYSIS ENCEPHALOPATHY; COORDINATION CHEMISTRY;
D O I：
10.1016/j.ccr.2011.06.013
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
The aim of this review is to give a general view on the current status of the role of aluminium in human health and disease. The main aspects of aluminium metabolism in humans are covered, summarizing the state of knowledge on the absorption, distribution, retention and excretion of aluminium, giving particular emphasis to the main metabolic pathways of this metal ion in different organs. Then the pathological consequences of aluminium overload in man, its role in neurodegenerative diseases and the emerging implication of this metal ions in different pathologies are treated. Finally, the function of different chelators utilized in clinical practice in the therapy of aluminium depending diseases is discussed and the latest studies on aluminium chelators are presented. Some emphasis is given to the parallelism between iron and aluminium chelators, and in particular interesting correlations between structural parameters of these two trivalent metal ions are presented. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：89 / 104
页数：16
相关论文
共 274 条
  • [21] Arenas MD, 2008, NEFROLOGIA, V28, P168
  • [22] Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996)
    Artursson, P
    Palm, K
    Luthman, K
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 27 - 43
  • [23] Fatty acids increase paracellular absorption of aluminium across Caco-2 cell monolayers
    Aspenstrom-Fagerlund, Bitte
    Sundstrom, Birgitta
    Tallkvist, Jonas
    Ilback, Nils-Gunnar
    Glynn, Anders W.
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 181 (02) : 272 - 278
  • [24] Central nervous system disease in patients with macrophagic myofasciitis
    Authier, FJ
    Cherin, P
    Creange, A
    Bonnotte, B
    Ferrer, X
    Abdelmoumni, A
    Ranoux, D
    Pelletier, J
    Figarella-Branger, D
    Granel, B
    Maisonobe, T
    Coquet, M
    Degos, JD
    Gherardi, RK
    [J]. BRAIN, 2001, 124 : 974 - 983
  • [25] Synthesis of tetradentate mixed bisphosphonates -: new hydroxypyridinonate ligands for metal chelation therapy
    Bailly, T
    Burgada, R
    Prangé, T
    Lecouvey, M
    [J]. TETRAHEDRON LETTERS, 2003, 44 (01) : 189 - 192
  • [26] Towards a model of non-equilibrium binding of metal ions in biological systems
    Beardmore, James
    Exley, Christopher
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2009, 103 (02) : 205 - 209
  • [27] A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques
    Beauchemin, D
    Kisilevsky, R
    [J]. ANALYTICAL CHEMISTRY, 1998, 70 (05) : 1026 - 1029
  • [28] Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines
    Bergfors, E
    Björkelund, C
    Trollfors, B
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (11) : 691 - 697
  • [29] Bertholf R.L., 1988, HDB TOXICITY INORGAN
  • [30] Berthon G, 1996, COORDIN CHEM REV, V149, P241, DOI 10.1016/S0010-8545(96)90030-2
12345678910